The "Art" of Medicine and The "Smokescreen" of the Randomized Trial Off-Label Use of Vascular Devices

被引:5
作者
Ansel, Gary M. [1 ]
Jaff, Michael R. [2 ]
机构
[1] Univ Toledo, Sch Med, Ctr Crit Limb Care, Riverside Methodist Hosp, Columbus, OH 43214 USA
[2] Massachusetts Gen Hosp, Dept Med, Vasc Ctr, Div Cardiol Vasc Med, Boston, MA 02114 USA
关键词
peripheral vascular disease; stent; angioplasty; regulatory; off-label;
D O I
10.1002/ccd.21776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Once a device is approved for sale in the United States by the Food and Drug Administration (FDA), it can legally be used by doctors to treat any condition a physician determines is medically appropriate. Based on postmarket published data and physician procedural experience, this may even become the standard of care when an alternative device either does not exist or is inferior in performance, even before FDA approval. This right of physicians to practice medicine without FDA approval is Federal law. The off-label use of medical devices for the treatment of peripheral vascular disease has recently become the latest target by groups with interests that have little to do with patient care. This interference has begun to negatively impact the latitude necessary for physicians to best treat their patients. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:998 / 1002
页数:5
相关论文
共 50 条
  • [41] Off-label drug use in oncology: a systematic review of literature
    Saiyed, M. M.
    Ong, P. S.
    Chew, L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (03) : 251 - 258
  • [42] Off-label use of rhuFVIIa: Allegro ma non tropo
    Gris, J-C
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2013, 32 (10): : 650 - 652
  • [43] A guided framework for assessing off-label medication use in psychiatry
    Lehman, Kirk
    Aroney, Emeil
    AUSTRALASIAN PSYCHIATRY, 2024, 32 (01) : 63 - 67
  • [44] Physician's knowledge and experience with the off-label use of medicines
    Drenska, Maria
    Naseva, Emilia
    Getov, Ilko
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2021, 35 (01) : 111 - 116
  • [45] Off-label use of thalidomide for the treatment of a bleeding cutaneous metastasis
    Silvestri, Federico
    Da Porto, Andrea
    Labombarda, Antonella
    Mansutti, Elisa
    Rogato, Adolfo
    ITALIAN JOURNAL OF MEDICINE, 2015, 9 (04) : 377 - 379
  • [46] Off-label use of antipsychotics in the community pharmacy: The sex differences
    Rijcken, CAW
    Boelema, GJ
    Slooff, CJ
    Beuger, PJ
    Tanja, TA
    de Jong-van den Berg, LTW
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 187 - 191
  • [47] Off-label medication use in adult critical care patients
    Lat, Ishaq
    Micek, Scott
    Janzen, Jeffrey
    Cohen, Henry
    Olsen, Keith
    Haas, Curtis
    JOURNAL OF CRITICAL CARE, 2011, 26 (01) : 89 - 94
  • [48] Photodynamic therapy: Off-label and alternative use in dermatological practice
    Buggiani, G.
    Troiano, M.
    Rossi, R.
    Lotti, T.
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2008, 5 (02) : 134 - 138
  • [49] Off-label and unlicensed oncology medicine use in Turkey: a retrospective analysis of computer records of the Turkish Ministry of Health
    Kockaya, Guvenc
    Polat, Mine
    Vural, Ismail Mert
    Akbulat, Akif
    Dedeoglu, Burcak Deniz
    Akar, Halil
    Kerman, Saim
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2011, 2 (01) : 53 - 57
  • [50] Off-label prescription: developing a guideline and validating an instrument to measure physicians’ and clinical pharmacists’ knowledge and attitudes toward off-label medication use
    Pooneh Salari
    Bagher Larijani
    Farzaneh Zahedi
    Mahshad Noroozi
    Journal of Diabetes & Metabolic Disorders, 2023, 22 : 1599 - 1608